Skip to main content

Programme 2027

The meeting program is under construction.

Practical Information

Find information on access to the « Palais de la Bourse » and more…

Learn more

Contact

If you have any question, don't hesitate to contact us

Learn more

AVAM 2027 – Save the Date

Join us on Thursday, April 15 and Friday, April 16, 2027 at the Palais de la Bourse in Bordeaux.

Ne plus afficher

AVAM 2027 

Shaping the Future of Mitral and Tricuspid Therapies

Meeting Directors: Thomas Modine, Fabien Praz
Scientific Advisors: Joao Cavalcante, Lionel Leroux, Rodrigo Estevez-Loureiro, David Messika-Zeitoun, Marta Sitges, Nicolas Van Mieghem

From Integration to Interrogation

Mitral and tricuspid interventions are developing fast and have crossed borders. Transcatheter mitral valve repair is standard of care in many geographies and transseptal mitral replacement is approved on two continents. Tricuspid repair and replacement are reimbursed for an increasing number of patients based on rapidly growing randomized evidence. What was experimental five years ago is now on the shelf.

That is precisely why AVAM 2027 will not be a celebration. With therapy approval, more complex questions have emerged: Do our grading schemes measure disease severity or manufacturer trial eligibility? By the time our guidelines say intervene, is the ventricle already gone? Are we quantifying success, or the regurgitation our devices leave behind? And what about our treatment failure of today? Who will treat these patients in 2035, and how?

At AVAM 2027, nothing is exempted from critical cross-examination and everything will be put into questions again! Is it already the time to reexamine guidelines in the light of the new evidence and adapt cut-offs? The mitral and tricuspid guidelines will be questioned by their own authors. The Heart Team will have to argue for its continued existence. Established grading systems will be challenged by the people who proposed them. And the audience will vote before and after every debate to quantify the impact of mind-changing debates on the audience.

A Think Tank, Not a Podium

AVAM has built its identity as the forum where the mitral and tricuspid community argues productively. In Bordeaux, we will again gather interventional cardiologists, surgeons, heart failure specialists, electrophysiologists, imagers, engineers, and researchers and this year, intentionally, the people who usually stay outside the room. The investors, incubators, and entrepreneurs will open our meeting.

The intimate format remains AVAM's advantage: direct exchange between experts, innovators, industry, and the next generation. The conversations become new trials, devices, and collaborations.

Key themes of AVAM 2027

  • Beyond feasibility: durability, reproducibility, and the honest arithmetic of lifetime valve management.
  • AV valves and heart failure: controversial questions and new guidelines debated with the most influential heart failure experts. How to better interact with the heart failure community?
  • Digital transformation: what AI already decides in our workflows, what robotics has actually proven, and what remains to be achieved.
  • The eligibility question: who to select, who should be excluded, and the screen-failed patients the field leaves behind.
  • Follow the money: linking clinical research, regulation, investment, and real-world evidence because innovation without a funding path has no realistic future.

Knowledge Under Pressure

AVAM's method is exchange under pressure: live cases from Bordeaux showing real decisions rather than curated perfection, case-based controversies, late-breaking science, and debates structured so that convictions must be defended and justified, not only presented. Ideas that survive this room tend to survive contact with practice.

Building the Future, Honestly

The transformation of mitral and tricuspid care will not be completed by technology alone. It requires evidence we have not yet generated, access most of the world does not yet have, and the discipline to distinguish outcome-driven innovation from technology-driven seduction. AVAM 2027 is committed to that discipline and to the international community adopting this philosophy.

Join Us in Bordeaux

Come prepared to defend and explain what you do in your practice.

Together, we will:

  • Stress-test the evidence behind mitral and tricuspid therapies and identify what must be studied next.
  • Confront durability, patient selection, and the long-term consequences of today's procedural choices.
  • Connect clinicians, engineers, regulators, and investors around what it actually takes to bring a valve therapy to patients.
  • Define, and vote on, what the standards of 2030 should be.

The future of mitral and tricuspid intervention is being built today. Join the conversation. Bring your arguments. Be part of AVAM 2027.
On behalf of the Organising Committee,
 

T. Modine & F. Praz

Registration Fees

Healthcare professional:

1 020€ including VAT
(927.27€ ex. VAT)

Industry representative:

2 750€ including VAT 
(2 500.00€ ex. VAT)

 

These rates include: Participation in the entire meeting, coffee breaks, lunches and access to the partner area.

Registration opening soon 

Practical Information

Address

NEW ENTRANCE:

Palais de la Bourse
19 Place de la Bourse
33076 Bordeaux

How to get here?

Located in the heart of Bordeaux, near the river, the Palais de la Bourse benefits from an ideal situation, easily reachable with all types of transports.

The tramway allows a direct access to the rail wail station in 10 minutes (Line C, direction Parc des Expositions / Stade “Matmut Atlantique”, stop « Place de la Bourse ») and a shuttle brings you from the airport in 30 minutes (arrival Tourisme Office, 1-3 allée de Tourny).

By Tramway :
Line C : direct from Station Saint-Jean (10 min), direction Parc des Expositions / Stade “Matmut Atlantique”, stop « Place de la Bourse »

By car :
A10 (Bordeaux-Paris), A62 (Bordeaux-Toulouse), A63 (Bordeaux-Bayonne), A65 (Bordeaux-Pau), A89 (Bordeaux-Clermont-Lyon) et A8 (Bordeaux-Nice)
Parking under the Palais de la Bourse : 1 620 car parks.

 

ACCOMMODATION & TRAVEL

 BOOK YOUR HOTEL

 

Europa Booking & Services (EBS), the official and exclusive hotel management administrator for the Course. 

To help you find the best accommodation near the congress venue we have reserved bedrooms at preferred rates and conditions. 

Book your hotel

For your group request (up to 5 bedrooms) please contact EBS :

EUROPA BOOKING & SERVICES

Tél. : 05 34 45 64 13

E-mail : ebs@europa-group.com 

For individual reservations (less than 5 bedrooms) you can visit our website for online bookings: 

 

BOOK YOUR TRIP

Get on our website and book train or air tickets with a few simple clicks ! 

 

Book your trip

 

 

Partners

The AVAM would like to thank the following companies for their active support during the 2026 meeting:

Platinum

Medtronic

Gold

Abbott

Silver

Edwards
GE HealthCare
Jenscare
Meril
Philips
Terumo

Bronze

Anteris
Capstan Medical
Cardiac Dimensions
Haemonetics
HighLife
JENAVALVE
Materialise
Microport
Nyra Medical
Peijia
Pie Medical Imaging
Polares
Products and Features
Siemens
Simulands
Tricares
Valcare Medical

If you have any question, contact us...

PRIVACY POLICY

All fields marked with an asterisk are mandatory and the data we collect in order to respond to your request are processed in accordance with the Privacy Policy available here.

© 2026 - Europa Organisation - All rights reserved | Legal notice | Cookies | Privacy policy